S Negrotto, KP Ng, AM Jankowska, J Bodo… - Leukemia, 2011 - nature.com ... precursors. S Negrotto 1,6 , K P Ng 1,6 , A M Jankowska 1 , J Bodo 2 , B Gopalan 3 , K Guinta 1 , J C Mulloy 4 , E Hsi 2 , J Maciejewski 1,5 and Y Saunthararajah 1,5. ... Asterisks represent P<0.0001, except at the comparisons 'no met. change ...
S Knappskog, LM Myklebust, C Busch… - Annals of …, 2011 - Eur Soc Med Oncology ... Results: RINF expression was significantly higher in all tumor forms (primary breast, and thyroid cancers and metastatic melanomas) as compared with normal control tissues (P < 0.001 for each comparison). ... [12] (P = 10 −9 ; Mann–Whitney rank test). ... Related articles - All 2 versions
M Taylor, TL Bergemann, A Hussain… - Human Immunology, 2011 - Elsevier ... also conducted separately for BCP ALL and non-BCP leukemia, bringing the total number of tests to 96 (16 × 6). Decisions about statistical significance must account for these multiple comparisons, and because Bonferroni correction for type 1 error implies that p values less ... Related articles - All 2 versions
L Wang, A Gural, XJ Sun, X Zhao, F Perna… - Science, 2011 - sciencemag.org ... (D) Survival of mice receiving AE9a-transduced or AE9a mutant–transduced HSPCs (P < 0.0001, n = 15 per group). ... These p300 inhibitors significantly increased the median survival from 36 days to 54 days for Lys-CoA-Tat and from 32 days to 43 days for C646 (P < 0.0001; fig. ... Cited by 1